Determination of therapeutic and toxic plasma concentrations of the antipsychotic drug prothipendyl
- Conditions
- sedative agent within psychotic diseases
- Registration Number
- DRKS00011452
- Lead Sponsor
- Rechtsmedizin Bonn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
therapy with prothipendyl
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of plasma concentrations at defined time points after the intake of prothipendyl by high perfromance liquid chromatography mass spectrometry after single or chronic intake. <br><br>
- Secondary Outcome Measures
Name Time Method